EUVIMEDEUVIMED entdecken
Crossref

Synthesis and biological evaluation of indoline derivatives as CDGSH iron sulfur domain 2 activators

Chun-Hsu Yao, Lee-Ya Wang, Zhao-Qing Shen, Yu-Wen Huang, Chi-Hui Tsai, Jen-Shin Song, Chi-Han Chen, Yu-Chun Chen, Ting-Fen Tsai, Jinq-Chyi Lee

Bioorganic & Medicinal Chemistry · 2025

DOI: 10.1016/j.bmc.2025.118281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2025. Verfasst von Chun-Hsu Yao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 350, Taiwan. Hauptthemen laut MEDLINE: Indoles, Iron-Sulfur Proteins. Die Arbeit nennt 24 Literaturangaben. Gefördert von: National Health Research Institutes, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of indoline derivatives has been designed, synthesized, and evaluated for their capacity to activate CDGSH iron sulfur domain 2 (Cisd2), a protein implicated in nonalcoholic fatty liver disease (NAFLD), starting with 1-(2,3-dihydro-1H-indol-1-yl)-2-(4,5-dihydro-1,3-thiazol-2-ylsulfanyl)ethan-1-one 3 (EC50 = 569 nM), the hit identified through a two-stage screening strategy followed by substructure searches. Among them, indolines 7 (EC50 = 364 nM) and 10 (EC50 = 315 nM) stood out as the most potent Cisd2 activators and were advanced to in vivo studies. The data conclusively demonstrated that both compounds enhanced Cisd2 expression, yet only 7 effectively halted the development and progression of NAFLD without any detectable toxicity; compound 10 was linked to hepatotoxicity, highlighting its potential risks. Accordingly, the study provided proof of concept that compound 7 is a safe and orally active Cisd2 activator, supporting a therapeutic strategy for the treatment of NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndolesIron-Sulfur ProteinsHumansStructure-Activity RelationshipAnimalsNon-alcoholic Fatty Liver DiseaseMolecular StructureDose-Response Relationship, DrugMaleMice

Stichwörter der Autor:innen

Cisd2 activatorIndolineNonalcoholic fatty liver disease

Substanzen

IndolesindolineIron-Sulfur Proteins

Autor:innen und Institutionen

  • Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 350, Taiwan.
  • Department of Life Sciences and Institute of Genome Sciences, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.
  • Department of Life Sciences and Institute of Genome Sciences, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli 350,…
  • Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 350, Taiwan. Electronic address: jinqchyi@nhri.edu.tw.

Förderung

  • National Health Research Institutes
  • National Science and Technology Council

Zitieren

APA

Yao, C. H., Wang, L. Y., Shen, Z. Q., Huang, Y. W., Tsai, C. H., Song, J. S., Chen, C. H., Chen, Y. C., Tsai, T. F., & Lee, J. C. (2025). Synthesis and biological evaluation of indoline derivatives as CDGSH iron sulfur domain 2 activators. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2025.118281

Vancouver

Yao CH, Wang LY, Shen ZQ, Huang YW, Tsai CH, Song JS, et al. Synthesis and biological evaluation of indoline derivatives as CDGSH iron sulfur domain 2 activators. Bioorganic & Medicinal Chemistry. 2025. doi:10.1016/j.bmc.2025.118281

BibTeX
@article{Yao2025,
  author = {Yao, Chun-Hsu and Wang, Lee-Ya and Shen, Zhao-Qing and Huang, Yu-Wen and Tsai, Chi-Hui and Song, Jen-Shin and Chen, Chi-Han and Chen, Yu-Chun and Tsai, Ting-Fen and Lee, Jinq-Chyi},
  title = {Synthesis and biological evaluation of indoline derivatives as CDGSH iron sulfur domain 2 activators},
  journal = {Bioorganic & Medicinal Chemistry},
  year = {2025},
  doi = {10.1016/j.bmc.2025.118281}
}
Kostenlos starten →